propofol has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, L | 1 |
| Ning, M | 1 |
| Wang, W | 1 |
| Zheng, Y | 1 |
| Ma, L | 1 |
| Lv, J | 1 |
| Hernaiz Alonso, C | 1 |
| Tanner, JJ | 1 |
| Wiggins, ME | 1 |
| Sinha, P | 1 |
| Parvataneni, HK | 1 |
| Ding, M | 1 |
| Seubert, CN | 1 |
| Rice, MJ | 1 |
| Garvan, CW | 1 |
| Price, CC | 1 |
| Schneemilch, C | 1 |
| Fredriksson, A | 1 |
| Pontén, E | 1 |
| Gordh, T | 1 |
| Eriksson, P | 1 |
4 other studies available for propofol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Naringenin Prevents Propofol Induced Neurodegeneration in Neonatal Mice Brain and Long-Term Neurocognitive Impacts on Adults.
Topics: Animals; Behavior, Animal; Brain; Female; Flavanones; Male; Mice; Mice, Inbred C57BL; Neurodegenerat | 2020 |
Proof of principle: Preoperative cognitive reserve and brain integrity predicts intra-individual variability in processed EEG (Bispectral Index Monitor) during general anesthesia.
Topics: Aged; Anesthesia, General; Biological Variation, Individual; Biomarkers; Brain; Cognition; Cognitive | 2019 |
[General anaesthesia for neurological diseases].
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Br | 2010 |
Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits.
Topics: Analgesics; Anesthetics, Combined; Anesthetics, Intravenous; Animals; Animals, Newborn; Anti-Anxiety | 2007 |